| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.93B | 75.63B | 58.19B | 40.37B | 31.32B |
| Gross Profit | 30.86B | 33.63B | 28.97B | 24.68B | 19.97B |
| EBITDA | 17.75B | 16.94B | 13.82B | 11.60B | 8.48B |
| Net Income | 10.51B | 10.05B | 8.02B | 6.36B | 4.65B |
Balance Sheet | |||||
| Total Assets | 859.58B | 772.40B | 775.56B | 712.09B | 662.88B |
| Cash, Cash Equivalents and Short-Term Investments | 152.76B | 118.86B | 256.84B | 225.41B | 228.87B |
| Total Debt | 81.84B | 144.43B | 179.35B | 114.64B | 116.09B |
| Total Liabilities | 797.78B | 712.39B | 720.29B | 661.57B | 614.13B |
| Stockholders Equity | 57.36B | 55.65B | 51.70B | 46.90B | 43.91B |
Cash Flow | |||||
| Free Cash Flow | 117.30B | 32.74B | -2.54B | 21.28B | -2.19B |
| Operating Cash Flow | 118.13B | 33.94B | -721.00M | 23.72B | -1.24B |
| Investing Cash Flow | -104.57B | -53.55B | -1.42B | -3.91B | -1.63B |
| Financing Cash Flow | -3.67B | -2.57B | -1.84B | -7.56B | -4.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €74.81B | 13.79 | 15.73% | 4.05% | -7.50% | 12.76% | |
75 Outperform | €6.94B | 11.20 | 8.76% | 5.80% | -9.39% | 45.60% | |
73 Outperform | £156.31B | 12.01 | 12.91% | 1.82% | -16.49% | 14.32% | |
68 Neutral | €112.64B | 11.40 | 18.66% | 3.39% | 5.66% | 8.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | €16.29B | 10.57 | 7.75% | 7.43% | -6.77% | -39.63% | |
64 Neutral | €12.95B | 11.95 | 16.71% | 3.64% | -7.12% | 15.96% |